Indirubin derivative acts as dual inhibitor targeting proteasome and autophagy for treating multiple myeloma

被引：0
|
作者：
Fang, Teng [1 ]
Sun, Hao [1 ]
Sun, Xiyue [2 ]
Zhang, Xiaoyu [2 ]
Gong, Lixin [1 ]
Yu, Zhen [1 ]
Liu, Lanting [1 ]
Qiu, Lugui [1 ]
Hao, Mu [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol,Haihe Lab Cell Ecosyst, Tianjin 300020, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol, Tianjin, Peoples R China
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-189
引用
收藏
页码：S139 / S140
页数：2
相关论文
共 50 条
  • [31] Preclinical evaluation of tropolone and proteasome inhibitor therapy for multiple myeloma
    Holstein, Sarah
    Haney, Staci
    Varney, Michelle
    Smith, Lynette
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E130 - E131
  • [32] Next-generation proteasome inhibitor approved in multiple myeloma
    Katsnelson, Alla
    NATURE BIOTECHNOLOGY, 2012, 30 (11) : 1011 - 1012
  • [33] Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myeloma
    Staci L. Haney
    Michelle L. Varney
    Jacob T. Williams
    Lynette M. Smith
    Geoffrey Talmon
    Sarah A. Holstein
    Experimental Hematology & Oncology, 11
  • [34] Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myeloma
    Haney, Staci L.
    Varney, Michelle L.
    Williams, Jacob T.
    Smith, Lynette M.
    Talmon, Geoffrey
    Holstein, Sarah A.
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022, 11 (01)
  • [35] Geranylgeranyl Diphosphate Synthase Inhibitor and Proteasome Inhibitor Combination Therapy in Multiple Myeloma
    Haney, Staci L.
    Varney, Michelle L.
    Smith, Lynette M.
    Holstein, Sarah A.
    BLOOD, 2019, 134
  • [36] Targeting proteasome ubiquitin receptor Rpn13 in multiple myeloma
    Song, Y.
    Ray, A.
    Li, S.
    Das, D. S.
    Tai, Y. T.
    Carrasco, R. D.
    Chauhan, D.
    Anderson, K. C.
    LEUKEMIA, 2016, 30 (09) : 1877 - 1886
  • [37] Targeting proteasome ubiquitin receptor Rpn13 in multiple myeloma
    Y Song
    A Ray
    S Li
    D S Das
    Y T Tai
    R D Carrasco
    D Chauhan
    K C Anderson
    Leukemia, 2016, 30 : 1877 - 1886
  • [38] The combination of the MTOR inhibitor rapamycin and proteasome inhibitor bortezomib is synergistic in vitro in multiple myeloma
    Leleu, X.
    O'Sullivan, G.
    Jia, X.
    Ngo, H.
    Moreau, A. S.
    Roccaro, A.
    Hatjiharisi, F.
    Hideshima, T.
    Anderson, K.
    Ghobrial, I.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 148 - 149
  • [39] Indirubin Derivatives as Dual Inhibitors Targeting Cyclin-Dependent Kinase and Histone Deacetylase for Treating Cancer
    Cao, Zhuoxian
    Yang, Fenfen
    Wang, Jie
    Gu, Zhicheng
    Lin, Shuxian
    Wang, Pan
    An, Jianxiong
    Liu, Ting
    Li, Yan
    Li, Yongjun
    Lin, Hening
    Zhao, Yonglong
    He, Bin
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (20) : 15280 - 15296
  • [40] Multi-Omics Analysis of Proteasome Inhibitor Resistance in Multiple Myeloma
    Han, Seungbin
    Lee, Chien-Yun
    Besse, Lenka
    Munawar, Umair
    Besse, Andrej
    Hainold, Ann-Sohpie
    Nerreter, Silvia
    Vogt, Cornelia
    Kurian, Shilpa
    Zhou, Xiang
    Haertle, Larissa
    Waldschmidt, Johannes
    Driessen, Christoph
    Einsele, Hermann
    Rasche, Leo
    Kuster, Bernhard
    BLOOD, 2024, 144 : 6817 - 6818
12345